Corcept Therapeutics Inc. 13F holders
Of the 44 funds followed here, 9 reported a position in Corcept Therapeutics Inc. in a 13F for the quarter ended 30 June 2026. The largest: Renaissance Technologies, 5.3 million shares worth $457.5 million, 0.6% of its reported book.
| Fund | Shares | Value | Of its book | Change on the quarter | Status | Quarter ended | Filing |
|---|---|---|---|---|---|---|---|
| Renaissance Technologies | 5,261,628 | $457.5 million | 0.6% | -421,155 | trimmed | 30 June 2026 | 13F |
| FMR LLC | 3,337,618 | $290.2 million | 0.0% | +147,426 | added | 30 June 2026 | 13F |
| Geode Capital Management | 2,532,198 | $220.2 million | 0.0% | -181,321 | trimmed | 30 June 2026 | 13F |
| Two Sigma Investments | 610,078 | $53.0 million | 0.0% | -335,806 | trimmed | 30 June 2026 | 13F |
| Norges Bank | 487,055 | $42.3 million | 0.0% | held | 30 June 2026 | 13F | |
| Citadel Advisors | 425,705 | $37.0 million | 0.0% | -118,915 | trimmed | 30 June 2026 | 13F |
| Millennium Management | 216,167 | $18.8 million | 0.0% | -342,580 | trimmed | 30 June 2026 | 13F |
| Bridgewater Associates | 57,602 | $5.0 million | 0.0% | +19,180 | added | 30 June 2026 | 13F |
| Point72 Asset Management | 10,100 | $878,195 | 0.0% | -46,081 | trimmed | 30 June 2026 | 13F |
Value is what the fund reported.
Read more
Change is shares against the fund's previous 13F; a fund with one filing read shows no change. 13Fs cover long US positions of managers above $100 million and are filed up to 45 days after the quarter.Schedule 13D and 13G filed on the name, last twelve months
| Filed | Schedule | Who | Holding | Of the class | Event date | Rule or purpose | Filing |
|---|---|---|---|---|---|---|---|
| 13 August 2026 | 13G/A | Renaissance Technologies LLC and 3 others | 5.3 million | 4.9% | 1 April 2026 | passive, institutional (13d-1(b)) | EDGAR |
| 21 April 2026 | 13G/A | Ingalls & Snyder Llc and 1 other | 7.3 million | 6.8% | 31 December 2025 | passive, institutional (13d-1(b)) | EDGAR |
| 26 March 2026 | 13G/A | The Vanguard Group and 1 other | 0 | 0.0% | 13 March 2026 | passive, institutional (13d-1(b)) | EDGAR |
| 12 February 2026 | 13G/A | Renaissance Technologies LLC and 3 others | 5.8 million | 5.5% | 31 December 2025 | passive, institutional (13d-1(b)) | EDGAR |
A Schedule 13D is filed by anyone who crosses 5% of a class with intent to influence; a 13G by a passive holder.
Read more
Amendments (/A) report a change, including an exit to zero. Holding and percentage are as the filer stated them on the cover page; the purpose is the filer's own words, cut short.Fails to deliver
| Settlement date | Shares failed | Price | File |
|---|---|---|---|
| 3 September 2026 | 31,077 | $110.43 | SEC |
| 28 August 2026 | 399 | $116.93 | SEC |
| 21 August 2026 | 1,245 | $121.05 | SEC |
| 17 August 2026 | 9,969 | $114.47 | SEC |
Shares that failed to deliver at settlement, per day, from the SEC's half-month files, which arrive about two weeks after the period.
Read more
Largest in the window: 31,077 on 3 September 2026. A fail is an operational fact about settlement, not a position.Source
Each fund's 13F-HR on EDGAR, linked per row; positions matched to CORT by CUSIP from the SEC's own fails-to-deliver files; Schedule 13D and 13G from the company's own filing index, each read to confirm the company is the issuer named.
The same record on your computer
GreekSoup is also a free program for your own computer. It reads these same filings for the names you follow, refreshed as they land, with no account. One pasted line installs it.